These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 29361410)

  • 41. Young breast cancer: A single center experience.
    Gogia A; Raina V; Deo SV; Shukla NK; Mohanti BK
    Indian J Cancer; 2014; 51(4):604-8. PubMed ID: 26842210
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Triple-negative breast cancer types exhibit a distinct poor clinical characteristic in lymph node-negative Chinese patients.
    Liu ZB; Liu GY; Yang WT; Di GH; Lu JS; Shen KW; Shen ZZ; Shao ZM; Wu J
    Oncol Rep; 2008 Oct; 20(4):987-94. PubMed ID: 18813844
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Histological Features and Tissue Microarray Taxonomy of Nigerian Breast Cancer Reveal Predominance of the High-Grade Triple-Negative Phenotype.
    Titloye NA; Foster A; Omoniyi-Esan GO; Komolafe AO; Daramola AO; Adeoye OA; Adisa AO; Manoharan A; Pathak D; D'Cruz MN; Alizadeh Y; Lewis PD; Shaaban AM
    Pathobiology; 2016; 83(1):24-32. PubMed ID: 26730581
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Outcomes in young women with breast cancer of triple-negative phenotype: the prognostic significance of CK19 expression.
    Parikh RR; Yang Q; Higgins SA; Haffty BG
    Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):35-42. PubMed ID: 17855007
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Breast cancer in young women and prognosis: How important are proliferation markers?
    Fredholm H; Magnusson K; Lindström LS; Tobin NP; Lindman H; Bergh J; Holmberg L; Pontén F; Frisell J; Fredriksson I
    Eur J Cancer; 2017 Oct; 84():278-289. PubMed ID: 28844016
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Favorable prognosis in patients with T1a/T1bN0 triple-negative breast cancers treated with multimodality therapy.
    Ho AY; Gupta G; King TA; Perez CA; Patil SM; Rogers KH; Wen YH; Brogi E; Morrow M; Hudis CA; Traina T; McCormick B; Powell SN; Robson ME
    Cancer; 2012 Oct; 118(20):4944-52. PubMed ID: 22392492
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High incidence of triple-negative tumors in sub-saharan Africa: a prospective study of breast cancer characteristics and risk factors in Malian women seen in a Bamako university hospital.
    Ly M; Antoine M; Dembélé AK; Levy P; Rodenas A; Touré BA; Badiaga Y; Dembélé BK; Bagayogo DC; Diallo YL; Koné AA; Callard P; Bernaudin JF; Diallo DA
    Oncology; 2012; 83(5):257-63. PubMed ID: 22964749
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Comparison of breast cancer in young and old women based on clinicopathological features].
    Székely B; Madaras L; Szentmártoni G; Szász AM; Baranyák Z; Szittya L; Torgyík L; Zergényi E; Borbényi E; Kenessey I; Korompay A; Langmár Z; Bánhidy F; Kulka J; Dank M
    Magy Onkol; 2010 Mar; 54(1):19-26. PubMed ID: 20350864
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Locoregional recurrence and survival outcomes by type of local therapy and trastuzumab use among women with node-negative, HER2-positive breast cancer.
    Peterson DJ; Truong PT; Sadek BT; Alexander CS; Wiksyk B; Shenouda M; Raad RA; Taghian AG
    Ann Surg Oncol; 2014 Oct; 21(11):3490-6. PubMed ID: 24841346
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Patterns of recurrence in the basal and non-basal subtypes of triple-negative breast cancers.
    Nofech-Mozes S; Trudeau M; Kahn HK; Dent R; Rawlinson E; Sun P; Narod SA; Hanna WM
    Breast Cancer Res Treat; 2009 Nov; 118(1):131-7. PubMed ID: 19189211
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Negative margin status improves local control in conservatively managed breast cancer patients.
    Obedian E; Haffty BG
    Cancer J Sci Am; 2000; 6(1):28-33. PubMed ID: 10696736
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic factors in early-stage triple-negative breast cancer: lessons and limits from clinical practice.
    Pistelli M; Pagliacci A; Battelli N; Santinelli A; Biscotti T; Ballatore Z; Berardi R; Cascinu S
    Anticancer Res; 2013 Jun; 33(6):2737-42. PubMed ID: 23749934
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognostic values of negative estrogen or progesterone receptor expression in patients with luminal B HER2-negative breast cancer.
    Park C; Park K; Kim J; Sin Y; Park I; Cho H; Yang K; Bae BN; Kim KW; Ahn S; Gwak G
    World J Surg Oncol; 2016 Sep; 14(1):244. PubMed ID: 27619909
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognostic value of Ki67 expression in HR-negative breast cancer before and after neoadjuvant chemotherapy.
    Tan QX; Qin QH; Yang WP; Mo QG; Wei CY
    Int J Clin Exp Pathol; 2014; 7(10):6862-70. PubMed ID: 25400769
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Clinicopathologic features and prognosis of triple negative breast cancer].
    Zhou T; Yang L; Ma GM; Li CX; Bai Y; Zhao JA; Wang XL; Geng CZ
    Zhonghua Yi Xue Za Zhi; 2009 Aug; 89(32):2261-4. PubMed ID: 20095338
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Clinical characteristics and prognosis of different subtypes of breast cancer].
    Yuan ZY; Wang SS; Zhu MQ; Zheng L; Luo WB; Zhou ZM; Guan ZZ
    Zhonghua Zhong Liu Za Zhi; 2008 Jun; 30(6):456-61. PubMed ID: 19024523
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Prognosis impact of breast cancer adjuvant radiotherapy delay].
    Lesage M; Pilloy J; Fleurier C; Cirier J; Jourdan ML; Arbion F; Body G; Ouldamer L
    Gynecol Obstet Fertil Senol; 2019 Jun; 47(6):516-521. PubMed ID: 30851415
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Breast cancer presentation and therapy in migrant versus native German patients: contrasting and convergent data of a retrospective monocentric study.
    von Au A; Weiler U; Stefanovic S; Wallwiener M; Heil J; Golatta M; Rom J; Sohn C; Schneeweiss A; Schuetz F; Domschke C
    Arch Gynecol Obstet; 2016 Jul; 294(1):145-52. PubMed ID: 26538355
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Age as a prognostic factor in breast cancer: relationship to pathologic and biologic features.
    Bonnier P; Romain S; Charpin C; Lejeune C; Tubiana N; Martin PM; Piana L
    Int J Cancer; 1995 Jul; 62(2):138-44. PubMed ID: 7622286
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Outcome of Breast Cancer in Moroccan Young Women Correlated to Clinic-Pathological Features, Risk Factors and Treatment: A Comparative Study of 716 Cases in a Single Institution.
    Slaoui M; Mouh FZ; Ghanname I; Razine R; El Mzibri M; Amrani M
    PLoS One; 2016; 11(10):e0164841. PubMed ID: 27760178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.